Abstract. Aberrant expression of COX-2 occurs in many types of malignancies including colon and lung cancers, and is implicated in development and progression of cancer. The molecular mechanisms associated with aberrant expression of COX-2 in lung cancer cells remain to be fully elucidated. In this study, we found that non-small cell lung cancer (NSCLC) NCI-H520 and NCI-H460 cells constitutively expressed COX-2 and produced prostaglandin E 2 (PGE 2 ) as measured by Western blotting and enzyme-linked immunosorbent assay (ELISA), respectively. Reporter assays showed that transcriptional regulation of COX-2 was blunted when either the NF-IL6 (C/EBPß) or nuclear factor-κB (NF-κB) binding site in the COX-2 promoter was mutated, suggesting that C/EBPß and NF-κB transcription factors have an important role in aberrant expression of COX-2 in these lung cancer cells. In addition, the eight herbal mixture PC-SPES (Lot. 5431219) caused growth arrest and apoptosis of NCI-H520 and NCI-H460 cells in association with blockade of NF-κB and downregulation of C/EBPß, resulting in down-regulation of COX-2 and PGE 2 in these cells. On the other hand, PC-SPES upregulated the level of C/EBPß in these cells. Taken together, C/EBPß and NF-κB may be promising molecular targets for COX-2 inhibition in lung cancer cells. PC-SPES might be useful in the adjuvant setting for the treatment of individuals with resected NSCLC as well as other types of cancer in which COX-2 is activated.
IntroductionCyclooxygenase (COX) is the rate-limiting enzyme for the production of prostaglandins and thromboxanes from free arachidonic acid (1,2). Two forms of COX have been described; a constitutively expressed enzyme, COX-1 and an inducible enzyme, COX-2. COX-1 is ubiquitously expressed. COX-2 is an inducible protein which is an essential component of the inflammatory response, as well as involved in the repair of injury (3). Physiological activity of this enzyme provides a benefit to the organism; however, the aberrant or excessive expression of COX-2 has been implicated in a wide variety of pathologic processes including arthritis, carcinoma, as well as septic shock. Abnormal levels of this enzyme have been observed in many types of cancer including those from colon and lung; and studies implicate its involvement in development and progression of cancer (4-6). However, the molecular mechanisms of aberrant expression of COX-2 in cancer cells remain to be fully elucidated.PC-SPES contains a partially extracted mixture of eight herbs: Dendrantherma morifolium, Tzvel; Ganoderma Lucidium, Karst; Glycyrrhiza glabra L; Isatis indigotica, Fort; Panax pseudo-ginseng, Wall; Rabdosia rubescens; Scutellaria baicalensis, Georgi and Serenoa repens (7). In previous studies, we and others have shown that PC-SPES mediated an antiproliferative effect on prostate cancer cells in vivo and in vitro (8,9). Recently, we showed that PC-SPES inhibited the proliferation of colon cancer cells and prevented polyp formation in a murine colon cancer model, the Apc min mouse (10). These...